Marcin Szumowski

President of the Board, Chief Executive Officer.

Marcin has over 15 years of experience in technology transfer, R&D project and life science investment management. He has been involved in preparation and management of more than 40 R&D and investment projects with a combined budget of over 200 million euro. He has founded and/or managed several life science start-ups, including Medicalgorithmics SA, where he was the CEO since its founding in 2005 until 2010. During that term he secured over 4 million PLN in private equity investment and over 4 million in matching public funds. He was also responsible for business development and oversaw the first products cleared for marketing in Europe (CE mark, 2008, 2009) and USA (FDA 510k approval, 2009). Medicalgorithmics currently is listed on the Warsaw Stock Exchange (GPW, ticker MDG) with market capitalization over 1.2 billion PLN (300M USD) and high percentage of export sales. Marcin has been responsible for establishing a technology transfer platform within a bio-tech-med cluster (BTM Mazovia) formed around a 100 million euro Centre for Preclinical Research and Technology (CePT) investment project. The cluster brings together the three largest Warsaw universities, seven Polish Academy of Science institutes, several Polish biotech and biomed companies, VC and seed funds. He’s also a member of the GLG Institute. Since 2012 Marcin has also assisted the European Commission on independent expert panels performing the impact assessment and interim evaluations of the Innovative Medicines Initiative (IMI) the world’s largest public-private partnership (PPP) in pharmaceutical research.

MichałMarcin Szumowski